Skip to main content
Premium Trial:

Request an Annual Quote

OncoDNA Inks Exclusive Distribution Deal with BioSequence

NEW YORK (GenomeWeb) – Belgium-based OncoDNA today announced it has reached a distribution agreement with BioSequence, a Spanish personalized cancer genomics firm.

Under the terms of the agreement, BioSequence will become the exclusive Spanish distributor of OncoDNA's clinical oncology molecular diagnostics. OncoDNA offers OncoDeep Dx, which links specific genes to targeted cancer treatments, as well as other clinical cancer panels to measure translocations and protein presence and activity.

"BioSequence is a partner of choice to improve OncoDeep's use and awareness in Spain," Michäel Herman, OncoDNA's business development manager, said in a statement.

"We were very impressed by the OncoShare web platform," which offers clinicians clinically relevant interpretations of tumors sequencing results, said Adriana Terrádez, BioSequence's business development manager.

OncoDNA is affiliated with the Institute of Pathology and Genetics in Belgium.

In September 2014, OncoDNA signed an exclusive distribution deal in Greece with Istomedica.

The Scan

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.

Algorithm Teases Out Genetic Ancestry in Individuals at Biobank Scale

Researchers develop an algorithm known as Rye to tease apart ancestry fractions in admixed individuals at a biobank-scale, applying it to 488,221 UK Biobank participants in Nucleic Acids Research.

Multi-Ancestry Analysis Highlights Comparable Common Variants at Complex Trait-Linked Loci

Researchers in Nature Genetics examine common variants implicated in more than three dozen conditions, estimating genetic effect similarities across ancestry tracts in admixed individuals.

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.